Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent invasive pneumococcal disease in Canada: A Canadian Immunization Research Network (CIRN) study
Abstract The effectiveness of the 13-valent pneumococcal conjugate vaccine (PCV13) to prevent vaccine-serotype (VT) invasive pneumococcal disease (IPD) in children aged 2–59 months was assessed using data from 4 geographically defined areas in Canada with IPD surveillance, including immunization status. VT IPD cases an...